Phase IV Clinical TrialsCutting Edge Information
July 1, 2011
197 Pages - SKU: CIGQ6574218
More Clinical Trial reports by Cutting Edge Information
Oncology Clinical Trials Drug Development Resources and Case Studies by Cutting Edge Information
Delve into Oncology Clinical Trials: The Most Research-Active Therapeutic Area According to the US National Cancer Institute, 2012 saw 1.6 million newly diagnosed cancer cases ...
Pharmaceutical New Product Planning: Building the Framework for Brand Commercialization by Cutting Edge Information
Give Commercial Voice to Developing Brands Facing a fiercely competitive landscape and stringent payer demands, life science companies start shaping the commercial profiles of their ...
Optimizing Clinical Pharmacology Programs by Cutting Edge Information
Manage Phase I Cost-Drivers to Move Compounds through Early-Stage Trials Phase I is a pivotal step in a compound’s journey toward regulatory approval, as clinical ...
Launching Pharmaceutical Brands: Formulas for Commercialization Success by Cutting Edge InformationSee all reports like this >>
Get the Right Marketing Mix — and Ensure Quick Market Uptake In today’s competitive, payer-driven landscape, brand commercialization encompasses a dizzying range of undertakings. ...
More Europe Clinical Trial reports
Clinical Trials In Poland 2012 by PMR
Clinical trials in Poland 2012Development forecasts for 2012-2014Clinical trials in Poland 2012, Development forecasts for 2012-2014 delivers a complete description of current conditions in the ...
Clinical trials in Central Europe 2012 - Development forecasts for 2012-2014 by PMR
Clinical trials in Central Europe 2012Development forecasts for 2012-2014Clinical trials in Central Europe 2012, Development forecasts for 2012-2014 is PMR’s guide to prevailing conditions in ...
Clinical Trials in CIS Countries 2012 by PMR
Clinical trials in CIS countries 2012: Russia, Ukraine, Belarus and Georgia. Development forecasts for 2012-2014 Clinical trials in CIS countries 2012: Russia, ...
Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US by GBI ResearchSee all reports like this >>
Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the USSummaryGBI Research, the leading business intelligence provider, has ...
More Europe reports
European SMB Market Watch Update: January–March 2013 by IDC
This IDC Update presents coverage of the European SMB sector in the first quarter of 2013, with a focus on new products and services, initiatives, ...
Painters & Decorators - Scotland (UK) - Industry Report by Plimsoll Publishing Ltd.
Plimsoll Publishing’s UK Painters & Decorators - Scotland Analysis provides a detailed overview of the UK Painters & Decorators - Scotland market and delivers a ...
Tampons Market in Czech Republic to 2016 by Canadean Ltd
SynopsisThe report presents detailed data on consumption trends in the Tampons category in Czech Republic, analyzing consumption volumes and values. It also provides indispensable data ...
D&B Country Report: Portugal by Dun & Bradstreet Inc.See all reports like this >>
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
We can help you find what you need. Call us or write us:
Need help in your search?
Clinical Trial Reports
- Inflammatory Pain Global Clinical Trials Review, H1, 2013
- Cancer Pain Global Clinical Trials Review, H1, 2013
- Ascites Global Clinical Trials Review, H1, 2013
- Perspective: StudyOptimizer — Empowering Clinical Trial Enrollment Collaboration at Big Pharma
- Radiculopathy Global Clinical Trials Review, H1, 2013